Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptorepositive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study

Decker T, Fasching P, Nusch A, Hartkopf A, Heinrich BJ, Kurbacher CM, Fuchs R, Tesch H, Krabisch P, Huober J, Kuemmel S, Brucker SY, Janni W, Andreas S, Schuler M, Fehm TN, Lueftner D, Quiering C, Kreuzeder J, Reinisch M (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Annals of Oncology Elsevier

Publisher: ELSEVIER

City/Town: AMSTERDAM

Pages Range: S467-S468

Conference Proceedings Title: ANNALS OF ONCOLOGY

DOI: 10.1016/j.annonc.2021.08.530

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Eberhard Karls Universität Tübingen DE Germany (DE) Universitätsklinikum Heidelberg DE Germany (DE) Universität Duisburg-Essen (UDE) DE Germany (DE) Medizinisches Zentrum Bonn Friedensplatz DE Germany (DE) Klinikum Chemnitz DE Germany (DE) Universitätsklinikum Ulm DE Germany (DE) Novartis AG CH Switzerland (CH) Charité - Universitätsmedizin Berlin DE Germany (DE) Universitätsklinikum Düsseldorf DE Germany (DE) Kliniken Essen-Mitte DE Germany (DE) Kantonsspital St.Gallen CH Switzerland (CH) Centrum für Hämatologie und Onkologie Bethanien DE Germany (DE)

How to cite

APA:

Decker, T., Fasching, P., Nusch, A., Hartkopf, A., Heinrich, B.J., Kurbacher, C.M.,... Reinisch, M. (2021). Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptorepositive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study. In ANNALS OF ONCOLOGY (pp. S467-S468). AMSTERDAM: ELSEVIER.

MLA:

Decker, T., et al. "Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptorepositive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study." Proceedings of the ANNALS OF ONCOLOGY AMSTERDAM: ELSEVIER, 2021. S467-S468.

BibTeX: Download